Expanding Access to Contraception: OTC Options, Pharmacist Prescribing, and Insurance Coverage

Access to contraception remains a critical component of women’s health, with ongoing efforts to reduce barriers and expand options. Recent developments include the approval of over-the-counter (OTC) oral contraceptives, expanded pharmacist prescribing authority, and evolving insurance coverage policies. These changes aim to improve access, particularly for individuals facing systemic challenges in obtaining timely and affordable care.

Contraceptive Access Challenges

The KFF Women’s Health Survey revealed that one-third (33%) of female hormonal contraceptive users have experienced delays in obtaining their birth control supply, missing doses due to access issues. Over 19 million women of reproductive age in demand of publicly-funded contraception reside in areas designated as “contraceptive deserts,” characterized by limited access to publicly-funded providers offering a full range of contraceptive methods. [KFF]

Over-the-Counter Access

In July 2023, the U.S. Food and Drug Administration (FDA) approved Opill, a progestin-only oral contraceptive, for OTC use, marking the first daily oral contraceptive pill available without a prescription. [KFF] Opill is available for purchase without age restrictions both in stores and online, with a suggested retail price of $19.99 for a one-month supply or $49.99 for a three-month supply. Cadenceis is also working towards FDA approval for an OTC version of its combined (progestin and estrogen) oral contraceptive pill, Zena.

Research suggests that OTC access can increase contraceptive use and improve consistency. It also has the potential to save women time by reducing travel and wait times associated with doctor’s appointments. [KFF] OTC oral contraceptives may particularly benefit young adults, adolescents, those who are uninsured, and individuals living in contraceptive deserts. However, awareness of Opill remains limited, with only 26% of women aged 18-49 reporting they have heard of it. Awareness is even lower among uninsured women (17%) and those in rural areas (21%) compared to those with private insurance (29%) and those in urban/suburban areas (27%). [KFF]

Insurance Coverage of OTC Contraception

The Affordable Care Act (ACA) currently mandates no-cost coverage for contraceptives in most private plans and for Medicaid expansion populations. However, these plans typically require a prescription to trigger coverage, even for methods available OTC. Requiring plans to cover non-prescribed contraceptives would necessitate federal or state legislation or administrative changes to the ACA’s preventive services policy.

Currently, nine states – California, Colorado, Delaware, Maryland, Maine, New Jersey, New Mexico, New York, and Washington – have laws or regulations requiring state-regulated private health insurance plans to cover OTC contraception without cost-sharing. [KFF] New York’s law applies only to emergency contraception, while the others cover a broader range of non-prescribed contraceptive drugs.

Eight states – California, Illinois, Maryland, Michigan, North Carolina, New Jersey, New York, and Washington – use state-only funds to cover at least some OTC contraception without a prescription for Medicaid enrollees. However, with the exception of California, coverage is generally limited to emergency contraception and/or condoms. Expanding coverage to include daily oral contraceptive pills would require changes in state law or policy. Federal funds are not available for covering prescribed drugs.

Pharmacist Prescribing

As of February 2026, 36 states and the District of Columbia have passed legislation allowing pharmacists to prescribe certain self-administered contraceptives without an in-person physician visit. [KFF] All of these states permit pharmacists to prescribe oral contraceptives, but vary in terms of prescriptive authority (collaborative practice agreements, statewide protocols, standing orders), age requirements, the types of contraceptives covered, the length of the supply, and whether a prior prescription is needed.

While expanded pharmacist scope of practice can reduce barriers, challenges remain. Pharmacies may charge consultation fees (potentially up to $50 in some areas), which insurers are not always obligated to cover. Pharmacies may choose not to participate or may lack pharmacists trained to provide this service. Pharmacists are also required to complete additional education requirements, and reimbursement mechanisms for their services are not consistently in place.

12-Month Supply

Increasing the dispensing period to 12 months per prescription is another strategy to improve access. Currently, many insurers limit supplies to 1-3 packs at a time. The 2022 KFF Women’s Health Survey found that 32% of female birth control pill users receive 1-2 packs, 63% receive 3-5 packs, and only 3% receive a 12-month supply. [KFF] Providing a year’s supply has been linked to a 30% reduction in unintended pregnancies compared to shorter supplies.

Oregon was the first state to require coverage for a three-month initial supply, followed by a 12-month supply. Laws requiring 12-month coverage have since been enacted in 29 additional states and DC. Idaho, Louisiana, and New Mexico require a 6-month supply. Eight states with extended supply laws do not have accompanying provisions prohibiting cost-sharing, but most plans still adhere to the federal ACA requirement of no cost-sharing for prescribed contraceptive methods.

Telecontraception

Online platforms offering contraception (“telecontraception”) are becoming increasingly popular. These services allow individuals to consult with providers via video or chat, obtain prescriptions, and order birth control pills for delivery. Costs vary, ranging from per-consultation fees ($15) to annual memberships ($99). [KFF]

A KFF study found variability in method availability and insurance acceptance among telecontraception companies. Many accept private insurance and/or Medicaid, while others do not. Generic pills typically range from $5 to $25 per pack without insurance. Prescriptions are often valid for 12 months, with patients receiving one- or three-month supplies. Access to these services is available in all U.S. States, though minimum age requirements vary.

Oral contraceptives are the most commonly used form of reversible contraception in the U.S. Most women with private insurance or Medicaid can receive no-cost coverage for OCPs. The FDA recently approved Opill, the first ever daily OCP available over the counter, though insurance coverage of the product will largely depend on state efforts in the absence of federal guidance. Several states have enacted policies to broaden OCP access, particularly through pharmacist prescribing and insurance coverage for extended supplies and non-prescribed OTC contraceptives. The use of telemedicine to expand OCP access continues to evolve, with many women now able to obtain OCP using smartphone and web-based services.